These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32572869)

  • 1. [Screening of Mothers in a COVID-19 Low-Prevalence Region: Determination of SARS-CoV-2 Antibodies in 401 Mothers from Rostock by ELISA and Confirmation by Immunofluorescence].
    Reisinger EC; von Possel R; Warnke P; Geerdes-Fenge HF; Hemmer CJ; Pfefferle S; Löbermann M; Littmann M; Emmerich P
    Dtsch Med Wochenschr; 2020 Aug; 145(17):e96-e100. PubMed ID: 32572869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic.
    Perico L; Tomasoni S; Peracchi T; Perna A; Pezzotta A; Remuzzi G; Benigni A
    EBioMedicine; 2020 Nov; 61():103069. PubMed ID: 33130396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of the main haematological indexes and RNA detection for the diagnosis of SARS-CoV-2 infection.
    Xiang J; Chen Z; Zhou J; Tian D; Ran X; Zhang Z; Shi S; Xiao D; Zhou Y
    BMC Infect Dis; 2020 Oct; 20(1):779. PubMed ID: 33081702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders.
    Marklund E; Leach S; Axelsson H; Nyström K; Norder H; Bemark M; Angeletti D; Lundgren A; Nilsson S; Andersson LM; Yilmaz A; Lindh M; Liljeqvist JÅ; Gisslén M
    PLoS One; 2020; 15(10):e0241104. PubMed ID: 33085715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test.
    Meschi S; Colavita F; Bordi L; Matusali G; Lapa D; Amendola A; Vairo F; Ippolito G; Capobianchi MR; Castilletti C;
    J Clin Virol; 2020 Aug; 129():104539. PubMed ID: 32679298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
    To KK; Tsang OT; Leung WS; Tam AR; Wu TC; Lung DC; Yip CC; Cai JP; Chan JM; Chik TS; Lau DP; Choi CY; Chen LL; Chan WM; Chan KH; Ip JD; Ng AC; Poon RW; Luo CT; Cheng VC; Chan JF; Hung IF; Chen Z; Chen H; Yuen KY
    Lancet Infect Dis; 2020 May; 20(5):565-574. PubMed ID: 32213337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies.
    Velay A; Gallais F; Benotmane I; Wendling MJ; Danion F; Collange O; De Sèze J; Schmidt-Mutter C; Schneider F; Bilbault P; Meziani F; Fafi-Kremer S
    Diagn Microbiol Infect Dis; 2020 Dec; 98(4):115181. PubMed ID: 32957073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic changes in virology, specific antibody response and imaging during the clinical course of COVID-19: a descriptive study.
    Wang QJ; Yao YZ; Song JS; Wang Q; Xu LY; Bao ZJ; Mao DW; Zhou JH; Zhang ZE; Wang Y; Li YW; Wang HP; Li L; Pan HY; Zhang GQ; Li SB
    BMC Infect Dis; 2020 Nov; 20(1):818. PubMed ID: 33167900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019.
    Kowitdamrong E; Puthanakit T; Jantarabenjakul W; Prompetchara E; Suchartlikitwong P; Putcharoen O; Hirankarn N
    PLoS One; 2020; 15(10):e0240502. PubMed ID: 33035234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG.
    Sapkal G; Shete-Aich A; Jain R; Yadav PD; Sarkale P; Lakra R; Baradkar S; Deshpande GR; Mali D; Tilekar BN; Majumdar T; Kaushal H; Gurav Y; Gupta N; Mohandas S; Deshpande K; Kaduskar O; Salve M; Patil S; Gaikwad S; Sugunan AP; Ashok M; Giri S; Shastri J; Abraham P; Gangakhedkar RR;
    Indian J Med Res; 2020 May; 151(5):444-449. PubMed ID: 32611915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
    Liu R; Liu X; Yuan L; Han H; Shereen MA; Zhen J; Niu Z; Li D; Liu F; Wu K; Luo Z; Zhu C
    Int Immunopharmacol; 2020 Sep; 86():106746. PubMed ID: 32619956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.
    Hallal PC; Hartwig FP; Horta BL; Silveira MF; Struchiner CJ; Vidaletti LP; Neumann NA; Pellanda LC; Dellagostin OA; Burattini MN; Victora GD; Menezes AMB; Barros FC; Barros AJD; Victora CG
    Lancet Glob Health; 2020 Nov; 8(11):e1390-e1398. PubMed ID: 32979314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19).
    Guo L; Ren L; Yang S; Xiao M; Chang D; Yang F; Dela Cruz CS; Wang Y; Wu C; Xiao Y; Zhang L; Han L; Dang S; Xu Y; Yang QW; Xu SY; Zhu HD; Xu YC; Jin Q; Sharma L; Wang L; Wang J
    Clin Infect Dis; 2020 Jul; 71(15):778-785. PubMed ID: 32198501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Validity of Serum Antibodies to SARS-CoV-2 : A Case-Control Study.
    Caturegli G; Materi J; Howard BM; Caturegli P
    Ann Intern Med; 2020 Oct; 173(8):614-622. PubMed ID: 32628534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.
    Lahner E; Dilaghi E; Prestigiacomo C; Alessio G; Marcellini L; Simmaco M; Santino I; Orsi GB; Anibaldi P; Marcolongo A; Annibale B; Napoli C
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32575505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay.
    Lau CS; Hoo SP; Yew SF; Ong SK; Lum LT; Heng PY; Tan JG; Wong MS; Aw TC
    J Appl Lab Med; 2020 Nov; 5(6):1313-1323. PubMed ID: 32717060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cell-Based ELISA to Improve the Serological Analysis of Anti-SARS-CoV-2 IgG.
    Zarletti G; Tiberi M; De Molfetta V; Bossù M; Toppi E; Bossù P; Scapigliati G
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33171590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation.
    Jääskeläinen AJ; Kuivanen S; Kekäläinen E; Ahava MJ; Loginov R; Kallio-Kokko H; Vapalahti O; Jarva H; Kurkela S; Lappalainen M
    J Clin Virol; 2020 Aug; 129():104512. PubMed ID: 32563180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies.
    Beavis KG; Matushek SM; Abeleda APF; Bethel C; Hunt C; Gillen S; Moran A; Tesic V
    J Clin Virol; 2020 Aug; 129():104468. PubMed ID: 32485620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.